A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
48.89 -0.33 (-0.67%) SLXP

Click Here to Receive Instant E-mail and RSS Alerts


Trade SLXP now with

Stock Details

Last Trade:48.89 Change:-0.33 (-0.67%) Prev Close:49.22 Open: 49.47 Days Range:48.80 – 49.81 52 Week Range: 25.64 - 50.28 Volume:222084 P/E: 36.76
EPS:1.33

Member Comments

No member comments available for SLXP


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 02/07/12 at 7:08am
Salix Pharmaceuticals' (SLXP) NDA for Crofelemer 125mg Tablets Receive Priority Review by FDA

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for the Company’s New Drug Application (NDA) for crofelemer 125 mg tablets for the proposed... Read More

Recent Alert on 02/06/12 at 2:08pm
Salix Pharma's (SLXP) Balsalazide Sodium Tablets Receive FDA Approval -Bloomberg
Recent Alert on 02/06/12 at 2:08pm
Salix Pharma's (SLXP) Balsalazide Sodium Tablets Receive FDA Approval -Bloomberg
Recent Alert on 01/23/12 at 7:43am
JMP Securities Downgrades Salix Pharmaceuticals (SLXP) to Market Perform
Recent Alert on 01/20/12 at 9:39am
Stifel Nicolaus Downgrades Salix Pharmaceuticals (SLXP) to Hold

View AllRecent Press Releases

Press Release on 02/07/12 at 7:00am
Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation for the Crofelemer NDA for Treatment of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy

View AllRecent SEC Filings

SEC Filing on 02/07/12 at 4:57pm
Form 4 SALIX PHARMACEUTICALS For: Feb 02 Filed by: CHAPPELL JOHN F
SEC Filing on 02/07/12 at 4:54pm
Form 4 SALIX PHARMACEUTICALS For: Feb 03 Filed by: Forbes William P
SEC Filing on 02/07/12 at 4:49pm
Form 4 SALIX PHARMACEUTICALS For: Feb 03 Filed by: DERBYSHIRE ADAM C

View AllRecent Blog Posts

Blog Posts on 01/23/12 at 7:19am
Nektar Therapeutics: Often Forgotten, But Worth A Look
Blog Posts on 01/23/12 at 2:16am
Analyzing Last Week's Noteworthy Insider Buys And Sells In Healthcare Sector
Blog Posts on 01/18/12 at 4:10pm
5 Specialty Pharma Stocks To Avoid
Blog Posts on 01/18/12 at 5:27am
18 Healthcare Stocks With A History Of Earnings Surprises
Blog Posts on 01/02/12 at 11:31am
Salix Pharma: Still Has Room To Run